Mayo Clinic Laboratories > Vector-borne disease testing

Vector-borne disease testing: The right test, the right patient, the right geographic area

StaY ahead of the spread with comprehensive testing

Climate change continues to enable the world’s smallest predators to move into previously uninhabitable regions. As ticks, mosquitoes, and other arthropod vectors migrate into and expand throughout new geographic areas, so too have the diseases they carry.1 Within the last two decades, more than 1 million cases of vector-borne diseases were reported in the U.S.2 While many vector-borne infections are not serious, some can become life-threatening. In fact, according to the U.S. Centers for Disease Control and Prevention, 161 individuals in the U.S. died from West Nile virus neuroinvasive disease in 2024.3

Staying up to date and educated on which vector-borne diseases are present in your region is the first step toward identifying appropriate testing to accurately diagnose patients.

Beyond Lyme disease

The presence of new and abundant tick species throughout North America has driven an increase in the diseases they carry. Because many vectors can transmit more than one disease-causing agent, the types of diseases occurring in certain regions are expanding as pests migrate to new regions.

While Lyme disease continues to be the most prevalent tick-borne disease, with 89,250 cases reported in the U.S. in 20234, other illnesses such as alpha-gal syndrome, anaplasmosis, babesiosis, ehrlichiosis, Powassan virus, and Rocky Mountain spotted fever are commonly identified throughout the United States. When point-of-care testing reveals that an infection is not Lyme disease, our algorithmic-based testing can quickly pinpoint the correct cause and help set patients on a path toward healing.

Learn more about the ticks that live in each region.

Expedite diagnosis through streamlined, algorithm-guided testing

Our algorithmic approach to vector-borne disease testing supports providing the right test to the right patient based on their geographic region of exposure. Our comprehensive vector-borne disease testing menu encompasses individual tests and panels for the detection of possible co-infections. Including testing for endemic illnesses, such as West Nile virus and Lyme disease, we have evaluations for emerging and esoteric diseases, such as alpha-gal syndrome, Powassan virus, spotted fever group rickettsial infections, ehrlichiosis, and tularemia, among others. We also offer testing for diseases imported by travelers, such as Chagas disease, Zika virus, dengue virus, and malaria. Providing physicians with the tools to accurately diagnose their patients enables appropriate treatment and improved patient outcomes. 

Learn more about how we can work together to support diagnosis of vector-borne disease.

Explore our comprehensive list of vector-borne testing. Schedule a time to discuss with one of our clinical specialists.


Resources

References
  1. Climate and Infectious Diseases. National Center for Emerging and Zoonotic Infectious Diseases (NCEZID). U.S. Centers for Disease Control and Prevention. https://www.cdc.gov/ncezid/topics-programs/climate-infectious-disease.html. Updated March 21, 2024. Accessed Jan. 5, 2026.
  2. United States Department of Health and Human Services; Centers for Disease Control and Prevention. The National Public Health Strategy to Prevent and Control Vector-Borne Diseases in People. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2024.
  3. West Nile Virus Historic Data (1991-2023). Centers for Disease Control and Prevention. https://www.cdc.gov/west-nile-virus/data-maps/historic-data.html. Updated Feb. 28, 2025. Accessed Jan. 5, 2026.
  4. Lyme Disease Surveillance and Data. U.S. Centers for Disease Control and Prevention. https://www.cdc.gov/lyme/data-research/facts-stats/index.html. Updated March 13, 2025. Accessed Jan. 5, 2026.